filmov
tv
Updates Informing the Management of ALK-rearranged mNSCLC
Показать описание
The standard of care for ALK-rearranged mNSCLC and a review of phase 3 global clinical trial data comparing the use of alectinib and brigatinib to crizotinib.
0:05:40
0:08:02
0:16:17
0:07:04
0:00:20
0:03:32
0:09:16
0:00:18
0:00:59
0:00:07
0:00:29
0:00:52
0:15:26
0:00:42
0:07:35
0:18:30
0:06:46
0:00:13
1:29:34
0:00:39
0:01:01
0:53:46
0:14:15
0:06:01